Transformed Non-Hodgkin Lymphoma — Trials

Transformed Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

75 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 25
Ph III recruiting: 0
Growth YoY: —
Industry share: 2%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03380026	Mechlorethamine Induced Contact Dermatitis Avoidance Study(MIDAS)	completed	Phase 2	28	Rochester Skin Lymphoma Medical Group, PLLCOTHER	1	Sep 4, 2026	clinicaltrials
NCT04703686	Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy	completed	Phase 2	67	The Lymphoma Academic Research OrganisationOTHER	1	Mar 16, 2026